36 Article(s)Download |
PMID | Title | Pub. Year | #Total Relationships |
1 | 23418897 | Involvement of c-Jun N-terminal kinase in reversal of multidrug resistance of human leukemia cells in hypoxia by 5-bromotetrandrine. | 2013 Nov | 2 |
2 | 21461383 | Non-viral systemic delivery of siRNA or antisense oligonucleotides targeted to Jun N-terminal kinase 1 prevents cellular hypoxic damage. | 2011 Feb | 1 |
3 | 18767140 | Activation of JNK and PAK2 is essential for citrinin-induced apoptosis in a human osteoblast cell line. | 2009 Aug | 3 |
4 | 19161988 | The NF kappa B-mediated control of RS and JNK signaling in vitamin A-treated cells: duration of JNK-AP-1 pathway activation may determine cell death or proliferation. | 2009 Apr 1 | 1 |
5 | 18403484 | Dexamethasone-induced expression of endothelial mitogen-activated protein kinase phosphatase-1 involves activation of the transcription factors activator protein-1 and 3',5'-cyclic adenosine 5'-monophosphate response element-binding protein and the generation of reactive oxygen species. | 2008 Jul | 1 |
6 | 18480747 | Induction of proapoptotic Daxx following ischemic acute kidney injury. | 2008 Aug | 1 |
7 | 18541008 | JNK supports survival in melanoma cells by controlling cell cycle arrest and apoptosis. | 2008 Aug | 1 |
8 | 15970429 | High glucose-induced apoptosis in human vascular endothelial cells is mediated through NF-kappaB and c-Jun NH2-terminal kinase pathway and prevented by PI3K/Akt/eNOS pathway. | 2006 Mar | 1 |
9 | 16889436 | JNK1 as a molecular target to limit cellular mortality under hypoxia. | 2006 Jul-Aug | 1 |
10 | 17299580 | Proteomic analysis of mechanisms of hypoxia-induced apoptosis in trophoblastic cells. | 2006 Dec 29 | 2 |
11 | 15677475 | Preheating accelerates mitogen-activated protein (MAP) kinase inactivation post-heat shock via a heat shock protein 70-mediated increase in phosphorylated MAP kinase phosphatase-1. | 2005 Apr 1 | 1 |
12 | 14699495 | Cyclooxygenase-2 inhibitor (SC-236) suppresses activator protein-1 through c-Jun NH2-terminal kinase. | 2004 Jan | 3 |
13 | 14724588 | Inhibition of JNK reduces G2/M transit independent of p53, leading to endoreduplication, decreased proliferation, and apoptosis in breast cancer cells. | 2004 Jan 15 | 2 |
14 | 15195070 | Paraptosis: mediation by MAP kinases and inhibition by AIP-1/Alix. | 2004 Oct | 2 |
15 | 12538493 | C-Jun NH(2)-terminal kinase mediates proliferation and tumor growth of human prostate carcinoma. | 2003 Jan | 2 |
16 | 12619033 | Requirement of c-jun for testosterone-induced sensitization to N-(4-hydroxyphenyl)retinamide-induced apoptosis. | 2003 Mar | 1 |
17 | 12760970 | C-Jun-NH2-terminal kinase mediates expression of connective tissue growth factor induced by transforming growth factor-beta1 in human lung fibroblasts. | 2003 Jun | 1 |
18 | 12847227 | c-Jun N-terminal kinase negatively regulates lipopolysaccharide-induced IL-12 production in human macrophages: role of mitogen-activated protein kinase in glutathione redox regulation of IL-12 production. | 2003 Jul 15 | 3 |
19 | 14532296 | Fibrillogenic amylin evokes islet beta-cell apoptosis through linked activation of a caspase cascade and JNK1. | 2003 Dec 26 | 4 |
20 | 14611688 | Specificity in stress response: epidermal keratinocytes exhibit specialized UV-responsive signal transduction pathways. | 2003 Oct | 1 |
21 | 12049842 | Microtubule damaging agents induce apoptosis in HL 60 cells and G2/M cell cycle arrest in HT 29 cells. | 2002 Jun 14 | 3 |
22 | 12183452 | Paclitaxel-resistant human ovarian cancer cells undergo c-Jun NH2-terminal kinase-mediated apoptosis in response to noscapine. | 2002 Oct 18 | 1 |
23 | 12221076 | Nocodazole-induced p53-dependent c-Jun N-terminal kinase activation reduces apoptosis in human colon carcinoma HCT116 cells. | 2002 Nov 15 | 1 |
24 | 11160861 | Involvement of Asp-Glu-Val-Asp-directed, caspase-mediated mitogen-activated protein kinase kinase 1 Cleavage, c-Jun N-terminal kinase activation, and subsequent Bcl-2 phosphorylation for paclitaxel-induced apoptosis in HL-60 cells. | 2001 Feb | 2 |
25 | 11278982 | c-Jun N-terminal kinase activation by hydrogen peroxide in endothelial cells involves SRC-dependent epidermal growth factor receptor transactivation. | 2001 May 11 | 1 |
26 | 10704932 | Inhibition of hypoxia/reoxygenation-induced apoptosis by an antisense oligonucleotide targeted to JNK1 in human kidney cells. | 2000 May 1 | 7 |
27 | 10839298 | Activation of SAPK/JNK by camptothecin sensitizes androgen-independent prostate cancer cells to Fas-induced apoptosis. | 2000 Jun | 1 |
28 | 10840014 | High glucose-induced apoptosis in human endothelial cells is mediated by sequential activations of c-Jun NH(2)-terminal kinase and caspase-3. | 2000 Jun 6 | 1 |
29 | 10998365 | Apoptotic signalling cascade in photosensitized human epidermal carcinoma A431 cells: involvement of singlet oxygen, c-Jun N-terminal kinase, caspase-3 and p21-activated kinase 2. | 2000 Oct 1 | 3 |
30 | 11103806 | The role of c-Jun kinase in the apoptotic response to nucleoside analogue-induced DNA damage. | 2000 Nov 15 | 2 |
31 | 9927052 | Activation of c-Jun NH2-terminal kinase and subsequent CPP32/Yama during topoisomerase inhibitor beta-lapachone-induced apoptosis through an oxidation-dependent pathway. | 1999 Jan 15 | 2 |
32 | 10200552 | IL-2 deprivation triggers apoptosis which is mediated by c-Jun N-terminal kinase 1 activation and prevented by Bcl-2. | 1999 Jan | 1 |
33 | 9790925 | Interleukin-1 beta and reactive oxygen species mediate activation of c-Jun NH2-terminal kinases, in human epithelial cells, by two independent pathways. | 1998 Oct 9 | 1 |
34 | 9020192 | c-Jun NH2-terminal kinase-mediated activation of interleukin-1beta converting enzyme/CED-3-like protease during anticancer drug-induced apoptosis. | 1997 Feb 14 | 3 |
35 | 9115218 | Hypoglycemia-induced c-Jun phosphorylation is mediated by c-Jun N-terminal kinase 1 and Lyn kinase in drug-resistant human breast carcinoma MCF-7/ADR cells. | 1997 May 2 | 1 |
36 | 9407138 | The JUN kinase/stress-activated protein kinase pathway is required for epidermal growth factor stimulation of growth of human A549 lung carcinoma cells. | 1997 Dec 26 | 3 |